Bluejay Diagnostics (BJDX) Other Accumulated Expenses (2020 - 2026)
Bluejay Diagnostics (BJDX) posted Other Accumulated Expenses of $104829.0 for Q1 2026, down 33.05% sequentially from $156567.0 in Q4 2025, and up 0.61% YoY from $104194.0 in Q1 2025.
Bluejay Diagnostics (BJDX) Other Accumulated Expenses (2020 - 2026) Analysis & Trends
Bluejay Diagnostics has reported Other Accumulated Expenses for 6 years, with the latest figure at $104829.0 in Q1 2026.
- Quarterly Other Accumulated Expenses rose 0.61% year-over-year to $104829.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $104829.0 (up 0.61% YoY) and the FY2025 annual result came in at $156567.0, up 35.58% from the prior year.
- Other Accumulated Expenses declined to $104829.0 in Q1 2026 per BJDX's latest filing, from $156567.0 in the prior quarter.
- Over five years, Other Accumulated Expenses peaked at $231635.0 in Q3 2024 and troughed at $104194.0 in Q1 2025.
- A 4-year average of $154209.1 and a median of $156567.0 in 2025 frame the typical range for Other Accumulated Expenses.
- The sharpest annual moves came in 2024 and 2025: Other Accumulated Expenses dropped 25.29% in 2024, then surged 35.58% in 2025.
- Over 4 years, Other Accumulated Expenses stood at $154575.0 in 2023, then decreased by 25.29% to $115479.0 in 2024, then jumped by 35.58% to $156567.0 in 2025, then slumped by 33.05% to $104829.0 in 2026.
- According to Business Quant data, Other Accumulated Expenses over the past three periods registered $104829.0, $156567.0, and $189088.0 for Q1 2026, Q4 2025, and Q3 2025 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 198.70 Bn | 193.10 Bn | 7.27 Bn |
| 2 | Stryker | 125.85 Bn | 122.37 Bn | 4.50 Bn |
| 3 | Medtronic | 118.44 Bn | 109.22 Bn | 6.41 Bn |
| 4 | Boston Scientific | 72.64 Bn | 72.10 Bn | 3.85 Bn |
| 5 | Edwards Lifesciences | 51.94 Bn | 47.69 Bn | 1.35 Bn |
| 6 | Dexcom | 34.48 Bn | 32.53 Bn | 830.00 Mn |
| 7 | GE HealthCare Technologies | 33.60 Bn | 31.49 Bn | 2.18 Bn |
| 8 | Koninklijke Philips | 26.30 Bn | 22.98 Bn | 4.55 Bn |
| 9 | Steris | 23.00 Bn | 22.52 Bn | 684.20 Mn |
| 10 | Bluejay Diagnostics | 1.91 Mn | 1.91 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 138,136.00 |
| Mar 31, 2026 | 104,829.00 |
| Dec 31, 2025 | 156,567.00 |
| Sep 30, 2025 | 189,088.00 |
| Jun 30, 2025 | 160,256.00 |
| Mar 31, 2025 | 104,194.00 |
| Dec 31, 2024 | 115,479.00 |
| Sep 30, 2024 | 231,635.00 |
| Jun 30, 2024 | 171,259.00 |
| Dec 31, 2023 | 154,575.00 |
| Dec 31, 2021 | 181,446.00 |
| Dec 31, 2020 | 133,820.00 |